Hypercoagulability and ACTH-dependent hyperadrenocorticism in dogs

Journal of Veterinary Internal Medicine

Volumn 27, Issue 5, 2013, Pages 1136-1142

  Park, F M ^a,b   Blois, S L ^a   Abrams Ogg, A C G ^a   Wood, R D ^a   Allen, D G ^a   Nykamp, S G ^a   Downie, A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b Animal Referral Hospital   (Australia)

Author keywords

Cushing's disease; Hemostasis; Platelet; Thrombelastography; Thromboembolism

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

ANIMAL; BLOOD; BLOOD ANALYSIS; COMPLICATION; DOG; DOG DISEASES; HYPERALDOSTERONISM; PATHOLOGY; THROMBOELASTOGRAPHY; THROMBOPHILIA; VETERINARY;

ANIMALS; BLOOD CHEMICAL ANALYSIS; DOG DISEASES; DOGS; HYPERALDOSTERONISM; THROMBELASTOGRAPHY; THROMBOPHILIA;

EID: 84884209637     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/jvim.12162     Document Type: Article

References (50)

1. Feldman E, Nelson R. Hyperadrenocorticism. In: Feldman E, Nelson R, eds. Canine and Feline Endocrinology and Reproduction, 3rd ed. St. Louis, MO: Saunders; 2004:252-393.
2. Boswood A, Lamb CR, White RN. Aortic and iliac thrombosis in six dogs. J Small Anim Pract 2000;41:109-114.
3. Burns MG, Kelly AB, Hornof WJ, Howerth EW. Pulmonary artery thrombosis in three dogs with hyperadrenocorticism. J Am Vet Med Assoc 1981;178:388-393.
4. Ramsey CC, Burney DP, Macintire DK, Finn-Bodner S. Use of streptokinase in four dogs with thrombosis. J Am Vet Med Assoc 1996;209:780-785.
5. Johnson LR, Lappin MR, Baker DC. Pulmonary thromboembolism in 29 dogs: 1985-1995. J Vet Intern Med 1999;13:338-345.
6. LaRue MJ, Murtaugh RJ. Pulmonary thromboembolism in dogs: 47 cases (1986-1987). J Am Vet Med Assoc 1990;197:1368-1372.
7. Wiinberg B, Jensen AL, Rojkjaer R, et al. Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Vet Clin Pathol 2005;34:389-393.
8. Donahue SM, Otto CM. Thromboelastography: A tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis. J Vet Emerg Crit Care 2005;15:9-16.
9. Goodwin LV, Goggs R, Chan DL, Allenspach K. Hypercoagulability in dogs with protein-losing enteropathy. J Vet Intern Med 2011;25:273-277.
10. Fenty RK, Delaforcade AM, Shaw SE, O'Toole TE. Identification of hypercoagulability in dogs with primary immune-mediated hemolytic anemia by means of thromboelastography. J Am Vet Med Assoc 2011;238:463-467.
11. Goggs R, Wiinberg B, Kjelgaard-Hansen M, Chan DL. Serial assessment of the coagulation status of dogs with immune-mediated haemolytic anaemia using thromboelastography. Vet J 2011;191:347-353.
12. Sinnott VB, Otto CM. Use of thromboelastography in dogs with immune-mediated hemolytic anemia: 39 cases (2000-2008). J Vet Emerg Crit Care (San Antonio) 2009;19:484-488.
13. Otto CM, Rieser TM, Brooks MB, Russell MW. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000;217:1500-1504.
14. Kristensen AT, Wiinberg B, Jessen LR, et al. Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia. J Vet Intern Med 2008;22:140-147.
15. Vilar Saavedra P, Lara Garcia A, Zaldivar Lopez S, Couto G. Hemostatic abnormalities in dogs with carcinoma: A thromboelastographic characterization of hypercoagulability. Vet J 2011;190:e78-e83.
16. Wagg CR, Boysen SR, Bedard C. Thrombelastography in dogs admitted to an intensive care unit. Vet Clin Pathol 2009;38:453-461.
17. Craft RM, Chavez JJ, Bresee SJ, et al. A novel modification of the thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med 2004;143:301-309.
18. Brainard BM, Kleine SA, Papich MG, Budsberg SC. Pharmacodynamic and pharmacokinetic evaluation of clopidogrel and the carboxylic acid metabolite sr 26334 in healthy dogs. Am J Vet Res 2010;71:822-830.
19. Rijnberk A, van Wees A, Mol JA. Assessment of two tests for the diagnosis of canine hyperadrenocorticism. Vet Rec 1988;122:178-180.
20. Feldman EC, Stabenfeldt GH, Farver TB, Addiego LA. Comparison of aqueous porcine ACTH with synthetic ACTH in adrenal stimulation tests of the female dog. Am J Vet Res 1982;43:522-524.
21. Kerl ME, Peterson ME, Wallace MS, et al. Evaluation of a low-dose synthetic adrenocorticotropic hormone stimulation test in clinically normal dogs and dogs with naturally developing hyperadrenocorticism. J Am Vet Med Assoc 1999;214:1497-1501.
22. Behrend EN, Kemppainen RJ, Bruyette DS, et al. Intramuscular administration of a low dose of ACTH for ACTH stimulation testing in dogs. J Am Vet Med Assoc 2006;229:528-530.
23. Feldman EC, Nelson RW, Feldman MS. Use of low- and high-dose dexamethasone tests for distinguishing pituitary-dependent from adrenal tumor hyperadrenocorticism in dogs. J Am Vet Med Assoc 1996;209:772-775.
24. Barthez P, Nyland T, Feldman E. Ultrasonographic evaluation of the adrenal glands in dogs. J Am Vet Med Assoc 1995;207:1180.
25. Benchekroun G, de Fornel-Thibaud P, Rodriguez Pineiro MI, et al. Ultrasonography criteria for differentiating ACTH dependency from ACTH independency in 47 dogs with hyperadrenocorticism and equivocal adrenal asymmetry. J Vet Intern Med 2010;24:1077-1085.
26. Brown S, Atkins C, Bagley R, et al. Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med 2007;21:542-558.
27. Beatrice L, Nizi F, Callegari D, et al. Comparison of urine protein-to-creatinine ratio in urine samples collected by cystocentesis versus free catch in dogs. J Am Vet Med Assoc 2010;236:1221-1224.
28. Lees GE, Brown SA, Elliott J, et al. Assessment and management of proteinuria in dogs and cats: 2004 ACVIM Forum Consensus Statement (small animal). J Vet Intern Med 2005;19:377-385.
29. Rose L, Dunn ME, Bedard C. Effect of canine hyperadrenocorticism on coagulation parameters. J Vet Intern Med 2012;27:207-211.
30. Flint SK, Abrams-Ogg AC, Kruth SA, et al. Independent and combined effects of prednisone and acetylsalicylic acid on thromboelastography variables in healthy dogs. Am J Vet Res 2011;72:1325-1332.
31. Klose TC, Creevy KE, Brainard BM. Evaluation of coagulation status in dogs with naturally occurring canine hyperadrenocorticism. J Vet Emerg Crit Care (San Antonio) 2011;21:625-632.
32. Teshima T, Hara Y, Taoda T, et al. Cushing's disease complicated with thrombosis in a dog. J Vet Med Sci 2008;70:487-491.
33. van der Pas R, de Bruin C, Leebeek FW, et al. The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy. J Clin Endocrinol Metab 2012;97:1303-1310.
34. Manetti L, Bogazzi F, Giovannetti C, et al. Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: Results from a prospective study before and after surgery. Eur J Endocrinol 2010;163:783-791.
35. Bell R, Neiger R, McGrotty Y, Ramsey IK. Study of the effects of once daily doses of trilostane on cortisol concentrations and responsiveness to adrenocorticotrophic hormone in hyperadrenocorticoid dogs. Vet Rec 2006;159:277-281.
36. Golde DW, Bersch N, Cline MJ. Potentiation of erythropoiesis in vitro by dexamethasone. J Clin Invest 1976;57:57-62.
37. Neel JA, Snyder L, Grindem CB. Thrombocytosis: A retrospective study of 165 dogs. Vet Clin Pathol 2012;41:216-222.
38. Buss DH, Stuart JJ, Lipscomb GE. The incidence of thrombotic and hemorrhagic disorders in association with extreme thrombocytosis: An analysis of 129 cases. Am J Hematol 1985;20:365-372.
39. Coon WW, Penner J, Clagett P, Eos N. Deep venous thrombosis and postsplenectomy thrombocytosis. Arch Surg 1978;113:429-431.
40. de Moerloose P, Boehlen F, Neerman-Arbez M. Fibrinogen and the risk of thrombosis. Semin Thromb Hemost 2010;36:7-17.
41. Palmer KG, King LG, Van Winkle TJ. Clinical manifestations and associated disease syndromes in dogs with cranial vena cava thrombosis: 17 cases (1989-1996). J Am Vet Med Assoc 1998;213:220-224.
42. Wiinberg B, Jensen AL, Johansson PI, et al. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med 2008;22:357-365.
43. Jacoby RC, Owings JT, Ortega T, et al. Biochemical basis for the hypercoagulable state seen in Cushing syndrome; discussion 1006-7. Arch Surg 2001;136:1003-1006.
44. Hibbetts K, Hines B, Williams D. An overview of proteinase inhibitors. J Vet Intern Med 1999;13:302-308.
45. Green RA. Pathophysiology of antithrombin III deficiency. Vet Clin North Am Small Anim Pract 1988;18:95-104.
46. Roeloffzen WW, Kluin-Nelemans HC, Mulder AB, et al. In normal controls, both age and gender affect coagulability as measured by thrombelastography. Anesth Analg 2010;110:987-994.
47. Ng KF. Changes in thrombelastograph variables associated with aging. Anesth Analg 2004;99:449-454, table of contents.
48. Goy-Thollot I, Pechereau D, Keroack S, et al. Investigation of the role of aldosterone in hypertension associated with spontaneous pituitary-dependent hyperadrenocorticism in dogs. J Small Anim Pract 2002;43:489-492.
49. Smets PM, Lefebvre HP, Meij BP, et al. Long-term follow-up of renal function in dogs after treatment for ACTH-dependent hyperadrenocorticism. J Vet Intern Med 2012;26:565-574.
50. Marino CL, Cober RE, Iazbik MC, Couto CG. White-coat effect on systemic blood pressure in retired racing Greyhounds. J Vet Intern Med 2011;25:861-865.